Crohn's Disease and Colitis Trial, Recruiting (NCT06858553)

Crohn's Disease and Colitis Trial, Recruiting NCT06858553 Sponsor: Minhu Chen Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06858553 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older and have been formally diagnosed with Crohn's disease according to established medical guidelines
You are scheduled to have a bowel (intestinal) surgery to remove a narrowed section in your small intestine or large intestine, and tissue samples from the removed section can be matched with your MRI scan images
The section of bowel being studied shows clear enough boundaries on imaging to allow accurate computer-assisted mapping of that area

Who may not be able to join:

You are unable to have an MRI scan for any reason
It would be difficult to collect usable tissue samples from the bowel after your surgery
Your MRI scan images are blurry, low quality, or have interference that affects the results
The narrowed section of bowel being studied is located at a join where two parts of the bowel were previously connected together (confirm with trial site)
The bowel problem exists alongside another separate disease affecting the same area (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Minhu Chen, First Affiliated Hospital, Sun Yat-Sen University

Phone: +86 13802957089

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06858553

Sponsor: Minhu Chen

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +86 13802957089

More information: https://clinicaltrials.gov/study/NCT06858553

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older and have been formally diagnosed with Crohn's disease according to established medical guidelines
You are scheduled to have a bowel (intestinal) surgery to remove a narrowed section in your small intestine or large intestine, and tissue samples from the removed section can be matched with your MRI scan images
The section of bowel being studied shows clear enough boundaries on imaging to allow accurate computer-assisted mapping of that area

Who may not be able to join:

You are unable to have an MRI scan for any reason
It would be difficult to collect usable tissue samples from the bowel after your surgery
Your MRI scan images are blurry, low quality, or have interference that affects the results
The narrowed section of bowel being studied is located at a join where two parts of the bowel were previously connected together (confirm with trial site)
The bowel problem exists alongside another separate disease affecting the same area (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Minhu Chen

Registry

ClinicalTrials.gov

Start date

3 June 2025

Est. completion

28 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

histologic inflammation score; histologic fibrosis score; Magnetization Transfer Ratio; Apparent Diffusion Coefficient; Percentage of Enhancement Gain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov